NOVUS THERAPEUTICS INC's ticker is NVUS and the CUSIP is 67011N105. A total of 14 filers reported holding NOVUS THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $58,000 | -40.8% | 12,499 | -10.4% | 0.00% | – |
| Q2 2018 | $98,000 | +36.1% | 13,946 | -6.3% | 0.00% | – |
| Q1 2018 | $72,000 | +18.0% | 14,879 | -5.1% | 0.00% | – |
| Q4 2017 | $61,000 | -25.6% | 15,679 | 0.0% | 0.00% | – |
| Q3 2017 | $82,000 | -10.9% | 15,679 | 0.0% | 0.00% | – |
| Q2 2017 | $92,000 | – | 15,679 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 80,069 | $1,233,000 | 0.56% |